REFERENCES:

1.  Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves
     endothelium -dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with
     coronary artery disease. Atherosclerosis 1997 Mar 21; 129(2):261-9.
2.  Slawinski M, Grodzinska L, Kostka-Trabka E, Bieron K, Goszcz A, Gryglewski RJ. L-Arginine - substrate for NO synthesis -
     its beneficial effects in therapy of patients with peripheral arterial disease: comparison with placebo - preliminary results.
     Acta Physiol Hung 1996; 84(4):457-8.
3.  Visek WJ. Arginine needs, physiological state, and usual diets. J Nutr 1986;116:36-46.
4.  Watanabe G, Tomiyama H, Doba N. Effects of oral administration of L-arginine on renal function in patients with heart
     failure. J Hypertens 2000 Feb;18(2):229-34.
5.  Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S,
     Iaina A, et al. Improvement of cardiac performance by intravenous infusion of l-arginine in patients
     with moderate congestive heart failure. J Am Coll Cardiol 1995 Nov 1;26(5):1251-6.
6.  Rector TS, Bank AJ, Mullen KA, Tschumperlin LK, Sih R, Pillai K, Kubo SH. Randomized, double-blind, placebo-controlled
     study of supplemental oral L-arginine in patients with heart failure.
     Circulation 1996 Jun 15;93(12):2135-41.
7.   Rector TS, Bunk AJ, Mullen KA et al. Randomized, double-blind, placebo-controlled study of
     supplemental oral L-arginine in patients with heart failure. Circ 1996;93:2135-41.
8.  Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction
     and improves exercise capacity in patients with chronic heart failure. Circ 1998;98:2709-15.
9.  Drexler H. Endothelial dysfunction. Prog Cardiovasc Dis 1997 Jan-Feb;39(4):287-324.
10. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G. Correction of
     endothelial dysfunction in chronic heart failure: additional effects of exercise training
     and oral L-arginine supplementation. J Am Coll Cardiol 2000;35(3):706-13.
11. Bachmann S, Mundel P. Nitric oxide in the kidney: synthesis, localization, and function.
     Am J Kidney Dis 1994 Jul;24(1):112-29.
12. Aiello S, Remuzzi G, Noris M. Nitric oxide/endothelin balance after nephron
     reduction.Kidney Int Suppl 1998 Apr;65:S63-7.
13. Wascher et al. Effects of low-dose L-arginine on insulin-mediated vasodilation
     and insulin sensitivity. Eur J Clin Invest 1997;27:690-5.
14. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill:a
     systematic review of clinical outcome.Crit Care Med '99 Dec 27(12):2799-805

Copyright 2012-2021 Betty Clarke.
All Rights Reserved.
Powered By FlexiSite